June 30, 2020 / 5:39 AM / 3 days ago

BRIEF-DiaSorin Launches LIAISON SARS-CoV-2 IgM Test In Europe And The U.S.

June 30 (Reuters) - DiaSorin SpA:

* LAUNCHES LIAISON SARS-COV-2 IGM IN EUROPE AND THE UNITED STATES

* LIAISON® SARS-COV-2 IGM IS NEW AUTOMATED SEROLOGICAL TEST TO IDENTIFY IMMUNE RESPONSE TO SARS-COV-2 IN PATIENTS WITH COVID-19 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below